China Medical University and its affiliated CMUH have jointed with Ever Supreme Bio Technology in the "Global Research & Industry Alliance (GLORIA) for Advanced Biotechnology and Medicine" and successfully transferred the technology of dendritic cell therapy and relevant technology (ADCV01 ) for continual research and applications to treat eight types of solid cancers with autologous dendritic cells (abbreviated as DC), including glioblastoma multiforme and secondary brain tumors, epithelial ovarian cancer, pancreatic cancer, and Guardian cancer, head and neck cancer, liver cancer, breast cancer and colorectal cancer. Ever Supreme is working together with medical facilities in innovation and breakthrough in the perspective future and active involvement as a driven force to Taiwan's biotechnological industry, and to provide innovative, effective, and precise personalized medical services, and move towards a new era of precision medicine.
.jpg)